SEIKAGAKU CORPORATION mainly manufactures complex-carbohydrate-base medicines and raw materials used for the pharmaceutical products.  The Company also manufactures and sells clinical reagents, diagnosis reagents, external medicine, medical equipment, and health food.

[Summary] Consolidated Financial Results (Japan Gaap) (Summary) For The First Six Months Of Fiscal 2025 (Six-Month Period Ended September 30, 2025)

[Summary] Consolidated Financial Results (Japan Gaap) (Summary) For The First Three Months Of Fiscal 2025 (Three-Month Period Ended June 30, 2025)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00